CompletedNot Applicable

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

Spain1,980 participantsStarted 2020-04-15

Plain-language summary

Observational, retrospective data collection and prospective IgG analysis, and multicenter study. The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients diagnosed with lung cancer at any stage of the disease
✓. Age ≥ 18
✓. Patients who have signed the informed consent for this study

What they're measuring

Description of the characteristics of patients

Timeframe: From the diagnosis of the COVID until the determination of the blood IgGs, up to 10 weeks

Trial details

NCT IDNCT04407143

SponsorFundación GECP

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-30

View on ClinicalTrials.gov More Lung Cancer trials